Literature DB >> 12354892

Erythromycin-resistant group A streptococcal isolates recovered in Sofia, Bulgaria, from 1995 to 2001.

Antoaneta Detcheva1, Richard R Facklam, Bernard Beall.   

Abstract

The frequency of erythromycin resistance within group A streptococci in Sofia, Bulgaria, from 1995 to 2001 was 2.1% (26 isolates). Of this, 57.7% was macrolide-lincosamide-streptogramin (MLS) inducible, 7.7% was MLS constitutive, and 34.6% had the M phenotype. Eleven different emm sequence types were found among 25 erythromycin-resistant isolates tested. Nineteen of 26 erythromycin-resistant isolates were additionally resistant to tetracycline and/or chloramphenicol.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12354892      PMCID： PMC130905          DOI： 10.1128/JCM.40.10.3831-3834.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

Review 1.  Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.

Authors:  M C Roberts; J Sutcliffe; P Courvalin; L B Jensen; J Rood; H Seppala
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

2.  Statement 1996 CA-SFM Zone sizes and MIC breakpoints for non-fastidious organisms.

Authors: 
Journal:  Clin Microbiol Infect       Date:  1996-02       Impact factor: 8.067

3.  Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, Germany.

Authors:  C M Brandt; M Honscha; N D Truong; R Holland; B Hövener; A Bryskier; R Lütticken; R R Reinert
Journal:  Microb Drug Resist       Date:  2001       Impact factor: 3.431

4.  Phenotypic and genotypic characterization of macrolide-resistant group A Streptococcus strains in the province of Quebec, Canada.

Authors:  K Weiss; J De Azavedo; C Restieri; L A Galarneau; M Gourdeau; P Harvey; J F Paradis; K Salim; D E Low
Journal:  J Antimicrob Chemother       Date:  2001-03       Impact factor: 5.790

5.  Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California.

Authors:  M K York; L Gibbs; F Perdreau-Remington; G F Brooks
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

6.  Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes.

Authors:  J Clancy; J Petitpas; F Dib-Hajj; W Yuan; M Cronan; A V Kamath; J Bergeron; J A Retsema
Journal:  Mol Microbiol       Date:  1996-12       Impact factor: 3.501

7.  A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes.

Authors:  H Seppälä; M Skurnik; H Soini; M C Roberts; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

Review 8.  Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain.

Authors:  E Perez-Trallero; J M Marimón; M Montes; B Orden; M de Pablos
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883

9.  Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.

Authors:  J Sutcliffe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

Review 10.  Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment.

Authors:  D L Stevens
Journal:  Emerg Infect Dis       Date:  1995 Jul-Sep       Impact factor: 6.883
View more
  6 in total

1.  Prevalence of group A streptococcal carriers in asymptomatic children and clonal relatedness among isolates in Malatya, Turkey.

Authors:  Riza Durmaz; Bengul Durmaz; Mehmet Bayraktar; Ibrahim Halil Ozerol; Mahmut Tayyar Kalcioglu; Elif Aktas; Zeynep Cizmeci
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients.

Authors:  Devrim Dundar; Murat Sayan; Gulden Sonmez Tamer
Journal:  Microb Drug Resist       Date:  2010-07-12       Impact factor: 3.431

3.  Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants.

Authors:  P Littauer; D A Caugant; M Sangvik; E A Høiby; A Sundsfjord; G S Simonsen
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

4.  Erythromycin-resistant group a streptococcal isolates collected between 2000 and 2005 in Oahu, Hawaii, and their emm types.

Authors:  Guliz Erdem; Jacqueline Ford; Dwight Johnson; Lucienne Abe; Karen Yamaga; Edward Kaplan
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

5.  Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin.

Authors:  Judith S Heelan; Meredith E Hasenbein; Alexander J McAdam
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

6.  Molecular characterization and evaluation of the emerging antibiotic-resistant Streptococcus pyogenes from eastern India.

Authors:  Dipanwita Ray; Somnath Saha; Sukanta Sinha; Nishith Kumar Pal; Basudev Bhattacharya
Journal:  BMC Infect Dis       Date:  2016-12-12       Impact factor: 3.090
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.